Hints and tips:
...Novo Nordisk is in talks with healthcare systems about innovative pricing deals for its Wegovy weight loss drug, as it hopes to expand take-up of the obesity treatment by helping health services spread the...
...Some users of Medicare, the US government-funded insurance programme for seniors, will be able to access weight-loss drugs if they suffer from certain conditions such as cardiovascular disease, officials...
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...Exploring the ESG impact of weight-loss drugs The surging popularity of obesity drugs is having a huge societal impact....
...But healthcare providers must also decide whether weight-loss drugs represent value for money....
...Denmark’s weight loss drugmaker Novo Nordisk is the best known example....
...Inspired by tales of celebrities’ dramatic weight loss, people are expected to widely adopt the weight-loss drugs — soon to be joined by Eli Lilly’s Mounjaro — potentially leading to seismic shifts in consumer...
...“This new agent is the most efficacious of the [weight-loss drugs] we have seen so far,” she said....
...Danish drugmaker Novo Nordisk developed semaglutide, branded as Ozempic for people with diabetes and Wegovy for weight loss....
...Novo Nordisk has become the largest company in Europe by market capitalisation because of soaring demand for its weight loss and diabetes drugs....
...The Centers for Medicare & Medicaid Services did not respond to a request for comment....
...Speaking of miracle cures to social ills, weight-loss drugs are still in demand, with Denmark’s Novo Nordisk and Eli Lilly of the US leading the charge....
...“These data reinforce our view that Mounjaro is the best injectable option for weight loss, besting Novo’s Wegovy,” he added....
...He added that Novo Nordisk’s and Eli Lilly’s blockbuster diabetes and weight loss drugs Ozempic and Mounjaro could be included on the list in 2027 and 2031 respectively....
...Those whose brains remain nimble and active seem better able to tolerate the deterioration of dementia without any obvious loss of faculties, a concept known as “cognitive reserve”....
...Amgen forecasts this mechanism will enable its drug to provide more durable weight loss than GLP-1 agonist drugs....
...Host Susan Burton focuses on a group of women who had IVF egg “retrievals” at the Yale Fertility Center....
...But in May, the safety issue resurfaced when the World Health Organization recommended that non-sugar sweeteners should not be used to support weight loss or the maintenance of healthy blood glucose levels...
...Research on pension holdings last week sought to give additional weight to these concerns....
...Anorexia is defined by low body weight, fear of weight gain and body-image disturbance....
...Eli Lilly said a late-stage trial of its new weight-loss drug showed it helped patients on high doses reduce their body weight by about a fifth, raising hopes among doctors and investors that it could become...
...Race is on to develop new generation of weight-loss drugs Changing attitudes, surging demand and tight supply for a new class of obesity drugs has sparked a race among several of the world’s largest pharmaceutical...
...Messi and Ronaldo also lost weight after shifting to radical long-term diets....
...North Koreans were said to be worried that his weight loss was a sign of the leader’s suffering, according to a report in state media....
...Typically fearful of the political spotlight, executives called unequivocally for a peaceful transfer of power in their home market as Donald Trump contested his election loss to Joe Biden....
International Edition